Sibutramine has a mechanism of action similar to that of antidepressants used as analgesics (like duloxetine). Limited data exists regarding the analgesic action of sibutramine.
Introduction:
1 Sibutramine is a serotonin (5HT) and norepinephrine (NE) reuptake inhibitor (SNRI) 2 approved for the treatment of obesity. It induces significant weight reduction in experimental 3 animals and human patients (Finer, 2002; Brown, 2001 ). Antidepressant drugs with a similar 4 mechanism of action, like venlafaxine and duloxetine show analgesic action in animal models 5 and humans, both in acute and chronic pain (Jones, 2005; Arnold, 2007) . Duloxetine have been 6 approved for clinical use in chronic pain syndromes (Russell, 2008) . The possibility that 7 sibutramine, despite its lack of antidepressant effect, could have analgesic properties is supported 8 by at least one publication using an experimental animal model of pain and two non-controlled, 9 non-randomized reports from clinical usage in humans (Gray, 1999; Palangio, 2002 ). It could be 10 possible that sibutramine could be used to treat painful conditions. There are scanty pre-clinical 11 and clinical reports of analgesic efficacy of sibutramine in published literature.
12
We sought to test sibutramine analgesic effect in widely used animal models of 13 nociception: writhing test in female mice and plantar thermal hyperalgesia test (Hargreaves, 14 1988) in female rats, and to evaluate catecholaminergic and alpha-2-adrenergic participation in 15 the latter model with reserpine and yohimbine pre-treatment. We also wanted to rule out motor 16 impairment or sedation with a rotarod test. Carrageenan-Induced Thermal Hyperalgesia. Plantar test was performed as previously 42 described (Hargreaves, 1988) . Briefly, each rat was placed in a Plexiglas cubicle with a glass 43 floor through which an infrared photo beam was shown onto the plantar surface of the hind paws 44 and the latency to withdrawal from the thermal stimulus was determined. The intensity of the 45 infrared photo beam from the plantar reflex device (Plantar Test, Ugo Basile) was adjusted to produce a withdrawal latency in untreated rats (SHAM) of approximately 10-12 s (mean 11 s).
17

Material and Methods:
47
The response latency was determined using a timer linked to the photodiode motion sensors in 48 the plantar reflex device. Response latency was defined as the time from the onset of exposure to 49 the infrared photo beam to the cessation of the photo beam when the photodiode motion sensors 50 detected the withdrawal response of the paw of the rat. Groups of 10 rats were injected s.c. with 51 -carrageenan (100 l of a 1.5% solution) into the plantar surface of the right hind paw at time experiments with sibutramine (data not reported). Oral doses of drugs were given through a 62 metal rodent feeding tube in a volume of less than 1.0ml, after fasting as described.
63
Rotarod Test. The effects of sibutramine on motor performance were evaluated using a Rotarod. The number of writhes for control group was 59.5 ± 14.1, whereas it was 27.5 ± 3.4 in hydrochloride monohydrate achieves pharmacological active concentrations when given orally to rodents, with a T max of 1 ± 0.7 h and a t 1/2 of 2.5 ± 1.7 h (Brown, 2001; Li, 2010 showed α2-adrenoceptors blockade could revert sibutramine anti-nociception (Gray, 1999) .
121
Although reserpine pretreatment is usually done for 24-48h in daily doses, this procedure yielded an almost complete depletion of striatum dopamine at 180 min after dose that persisted for more 129 than 6 h (Kannari, 2000) .
130
The exclusive use of male animal models when investigating diseases more frequent in 131 females, like painful syndromes, has been criticized. Research regarding gender differences in 132 pain sensation has increased substantially in recent years, after the publication of influential 133 reviews in the 90s. The relationship between sex and pain is not simple; nevertheless, most 134 population-based studies have found higher prevalence in women than in men. (Fillingim, 2009) 
135
The prevalence of most common forms of pain is higher among women than men, and women 136 report greater pain after invasive procedures than men, though these findings are less consistent.
137
Additionally, compared with men, women display enhanced sensitivity to most forms of experimentally induced pain (with the exception of ischemic pain). (Fillingim, 2009) (Gray, 1999) .
154
There has been considerable discussion at the experimental level about the nature and (Gray, 1999) . In the last decade, little was 158 added to this paradigm and it has been repeatedly demonstrated that antidepressant-induced 159 analgesia can be reverted by opioidergic antagonism (Sawynok, 2001 ) and depends partially on 160 α2A-adrenoceptors of spinal location but also on a variety of individual drug effects that goes 161 from serotonin (5HT) descending spinal signaling through peripheral ion channel blocking 162 (Sawynok, 2001) . Amitryptiline analgesia is lost in α2-adrenoceptors knock-out animals,
163
indicating that this receptor class is the main responsible for mediating tricyclic antidepressants 164 antinociception (Ozdogan, 2004) . Venlafaxine, a SNRI with a similar mechanism of action than 165 that of sibutramine, has been shown to induce α2-adrenoceptors-dependent analgesia (Sawynok, 166 2001); whereas duloxetine (other SNRI) had no analgesic effect in mice models where α2-167 adrenoceptor agonists show marked antinociception (Jones, 2005 
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